Drugs / lopinavir/ritonavir
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00978237 | Oct 2009 → Nov 2013 | HIV infectious disease, localized lipodystrophy | Juan A. Arnaiz | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | lopinavir/ritonavir | “or to switch from EFV to lopinavir/ritonavir (LPV/r).” PMID 27089862 ↗ Sep 2015 |
| Known as | LPV/r | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00978237 ↗ |
| Route | Oral | “2 pills QD VO” NCT00978237 ↗ |